Abstract
Purpose: The great efficacy of EGFR tyrosine kinase inhibitors (EGFR-TKIs) has been identified in patients with advanced non-small-cell lung cancer (N......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
